Subscribe to Newsletter

Profession

Discovery & Development Drug Discovery

Rewards in the Real World: Sitting Down With Igor Fisch

| 4 min read

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.

Business & Regulation Profession

The Blood Cancer Success Story: Part 2

| Stephanie Vine | 6 min read

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

Business & Regulation Profession

The Blood Cancer Success Story: Part 1

| Stephanie Vine | 7 min read

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society.

Business & Regulation Standards & Regulation

Peter Marks Resigns from FDA

| Stephanie Vine | 3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.

Business & Regulation Profession

Sitting Down With... Moncef Slaoui

| 5 min read

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

Manufacture Bioprocessing - Upstream & Downstream

Irish Horizons: Sitting Down With BMS’ Karen Costello

| 4 min read

General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.

Business & Regulation Contract Manufacturing Services

The Secret to Being a Good Employer

| 4 min read

Why you shouldn’t neglect the importance of blending people, culture, and strategy to foster success in a business.

Business & Regulation Profession

Maintaining Momentum

| 4 min read

Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, Oxford Biomedica.

Business & Regulation Standards & Regulation

Video Interview: Claus Zieler of Astellas and EFPIA

| Stephanie Vine

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3

| Stephanie Vine | 6 min read

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker